Diagnosing Pre-Menstrual Syndrome

Main Category: Women's Health / Gynecology
Also Included In: Depression;  Anxiety / Stress
Article Date: 03 Jan 2013 - 0:00 PST

Current ratings for:
Diagnosing Pre-Menstrual Syndrome

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:5 stars

5 (1 votes)

Article opinions: 1 posts

Even though there are many women who do not notice any special symptoms, there are some whose pre-menstrual disorders hamper their everyday lives: depressive mood, anxiety, excessive emotional sensitivity, fatigue, lack of concentration, headache, etc. Nevertheless, according to Leire Aperribai, PhD holder in Psychology from the UPV/EHU-University of the Basque Country, unified criteria for defining and diagnosing this disease have yet to be agreed on, "and so it is difficult to develop suitable interventions to treat women suffering from these symptoms."

Aperribai has sought to fill this gap through her PhD thesis. Her first task was to define the disorder, and to do this she took as her basis the 4th version of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association.

This manual defines premenstrual dysphoric disorder and proposes criteria for diagnosing it. For example, it explains that the symptoms are sufficiently serious to cause clear damage, socially as well as in the workplace, and points out that this takes place during the luteal phase, in other words, during the period between ovulation and menstruation. The manual also explains that the symptoms disappear at the onset of menstruation, and for it to be regarded as a disorder, it is necessary to display at least 5 symptoms related to it, and one of them has to be among the following: depressive mood, feelings of desperation or self-rejection; clear internal anxiety, tension, a feeling of not being able to take any more; clear emotional lability, in other words, sadness, bursting into tears or manifestations of emotional over-sensitiveness towards rejection by other people; and irascibility or irritability.

In Aperribai's view, the manual gives a special identity to premenstual dysphoric disorder, despite the fact that it is still classified among those described as "non-specific depressive disorders," so it constitutes a firm proposal as it takes the main groups of symptoms into consideration. Aperribai also added that among the current classifications, this is the one that has been most welcomed.

Reliable and useful

So, taking as the starting point the definitions and criteria provided by the manual, Aperribai has produced a set of questions and has validated them through interviews given by women who are either working or studying on any of the UPV/EHU's three campuses. And this way she has verified its reliability. In fact, and in accordance with current calculations, premenstrual dysphoric disorder is suffered by between 3% and 10% of the population; in the study done by Aperribai, by contrast, it has been found to affect 15%.

The author has explained that this difference is "normal because it concerns test screening. In other words, this is not a diagnostic tool, but a filter to distinguish those who suffer from the disorder from those who do not." In this respect, she has stressed its usefulness, both in the area of research and in health centres. It takes 10 minutes or less to do the test and a lot of progress can be made with it. After that, diagnostic tests are carried out in positive cases and these can take up to two months.

The title of the thesis is "An Evaluation of Premenstrual Dysphoric Disorder: building a screening tool" (Una evaluación del Trastorno Disfórico Premenstrual: construcción de una herramienta de screening). The test is currently being translated into Basque: "We've done one part, but there is still quite a way to go," she says.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our women's health / gynecology section for the latest news on this subject.
About the author:
Leire Aperribai (Arrasate-Mondragon, Basque Country, 1974) holds a PhD in Psychology and works in the Department of Psychological Identity, Evaluation and Treatments of the UPV/EHU-University of the Basque Country. She did her PhD thesis under the supervision of Itziar Alonso-Arbiol, associate professor of the Department of Psychological Identity, Evaluation and Treatments, and Nekane Balluerka-Lasa, professor of the Department of Social Psychology and Methodology of Behavioural Sciences, and is currently associate lecturer at the University College of Teacher Training of Nuestra Señora de Begoña.

The thesis has received funding from the UPV/EHU’s Rectorate for Basque. Several companies in the Basque Autonomous Community (region) have also participated either economically, materially or technically (Athletic Club Foundation, Eroski Foundation, Euskal Irrati Telebista, Fagor Arrasate, Cafés Fortaleza, In Faradis, Sintasys).

Elhuyar Fundazioa
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Fundazioa, Elhuyar. "Diagnosing Pre-Menstrual Syndrome." Medical News Today. MediLexicon, Intl., 3 Jan. 2013. Web.
20 Jun. 2013. <http://www.medicalnewstoday.com/releases/254437.php>

APA
Fundazioa, E. (2013, January 3). "Diagnosing Pre-Menstrual Syndrome." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/254437.php.

Please note: If no author information is provided, the source is cited instead.



Visitor Opinions (latest shown first)

The gastrointestinal bleeding countermeasures antiplatelet therapy after PCI

posted by medchemexpress on 22 Jan 2013 at 9:56 pm

The gastrointestinal bleeding countermeasures antiplatelet therapy after PCI

The results of a prospective randomized trial: the higher transfusion threshold, the lower mortality; the CHD subgroup Center Terrier and the incidence of pulmonary edema (target Hb :10.0-12 .0g/dl accept non-restrictive transfusion ), significantly increased; transfusion needs of patients with ACS with individual differences; restrictive transfusion (target Hb :7.0-9 .0g/dl) helps to maintain the hemoglobin exceeds 8g/dl; hemoglobin progressive ischemia or heart failure The target value is higher.

5.2 Interrupt antiplatelet therapy

Premature discontinuation of antiplatelet therapy is the strongest independent predictor of early stent thrombosis. Severe UGI bleeding, DAPT can be disabled for 24 hours, during this time, the need to assess the risk of persistent bleeding. The degree of injury according to GI bleeding 1-2 days can be re-taking clopidogrel, 1-2 weeks taking ASA.

5.3 UGI endoscopic examination and treatment

Early endoscopic reduce bleeding, blood transfusion, and the risk of surgical operations, but the application of sedatives risk of cardiopulmonary suppression. Low oxygen saturation under the premise of no myocardial ischemia or heart failure within 24 hours endoscopy, UGI bleeding. Combined with the results of endoscopy Rockall scoring system worked out. Rockall higher the score, the higher the risk. Rockall Score> 5 (bleeding the low-risk group): DAPT. Rockall Score ≥ 5 (high risk of bleeding group): Disable ASA, continue taking clopidogrel, ASA treatment start again in two weeks. Persistent GI bleeding: to stop ASA and clopidogrel, daily re-evaluate and re-treatment with clopidogrel in 1-2 weeks.

Endoscopic treatment techniques specific programs: active bleeding or visible blood vessels parts, the use of 10-20ml epinephrine injection (1:10000) associated with thermal probe line heat treatment or clip line mechanical treatment.

5.4 surgical treatment - coronary artery bypass grafting (CABG)

During hospitalization GPIIb / IIIa inhibitors, heparin (or low molecular weight heparin) transition antiplatelet therapy or both combined.

In short, as the PCI widespread popularity and strengthen the extensive application of antithrombotic drugs, intervene in the occurrence of serious postoperative bleeding complications will be increased. Antiplatelet therapy after PCI for prevention and control of bleeding and prevention of ischemic equally important, must be weighed against the benefits (ie reducing ischemic events) and risk (bleeding). Proper risk assessment before surgery, based on the fundamentals of clinical development of individualized antithrombotic program. Patients should be carefully observed condition, timely detection of serious bleeding and to take appropriate measures to stop the bleeding as soon as possible, to minimize bleeding caused harm.

| post followup | alert a moderator |


Add Your Opinion On This Article

'Diagnosing Pre-Menstrual Syndrome'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Women's Health / Gynecology

Most Popular Articles



Follow Our Women's Health News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Women's Health / Gynecology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »